FDA approves AbbVie's psoriasis blockbuster-to-be Skyrizi - PMLiVE

FDA approves AbbVie's psoriasis blockbuster-to-be Skyrizi  PMLiVE

AbbVie has bagged US approval for Skyrizi – a treatment for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or ...